<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ADXS
Ayala Pharmaceuticals
$
()


  • Immunome price target raised by $6 at Wedbush, here's why

    4/1/2024 - 07:59am
  • Ayala Pharmaceuticals completes sale of AL102 to Immunome

    3/26/2024 - 08:10am
  • Biotech Alert: Searches spiking for these stocks today

    2/9/2024 - 11:12am
  • Biotech Alert: Searches spiking for these stocks today

    2/8/2024 - 11:40am
  • Immunome to acquire AL102 from Ayala for $20M in cash, $30M in stock

    2/6/2024 - 08:21am
  • Ayala Pharmaceuticals downgraded to Neutral from Buy at Ladenburg

    11/16/2023 - 10:08am
  • Ayala Pharmaceuticals receives Orphan Drug Designation for AL102

    11/6/2023 - 08:21am
  • Ayala Pharmaceuticals treatment of desmoid tumors granted orphan designation

    11/2/2023 - 14:58pm
  • Ayala Pharmaceuticals presents updated AL102 results at ESMO congress

    10/23/2023 - 07:08am
  • Ayala Pharmaceuticals closes merger with Biosight

    10/19/2023 - 08:11am
  • Ayala Pharmaceuticals, Biosight enter definitive merger agreement

    7/27/2023 - 08:13am
  • Ayala announces End-of-Phase 2 meeting with FDA on AL102 in desmoid tumors

    7/5/2023 - 08:06am
  • Ayala Pharmaceuticals announces updated RINGSIDE Phase 2 results

    6/5/2023 - 08:32am
  • Ayala Pharmaceuticals upgraded to Buy from Neutral at Ladenburg

    5/30/2023 - 07:02am
  • Biotech Alert: Searches spiking for these stocks today

    5/19/2023 - 11:05am
dynamic_feed Breaking News